[1] Dietz HC, Cutting GR, Pyeritz RE, Masten CL, Sakai LY, Corson GM, Puffenberqer EG, Hamosh A, Nanthakumar EJ, Curristin SM. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 1991, 352(6333): 337–339.
[2] De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pveritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet, 1996, 62(4): 417–426.
[3] Collod-Beroud G, Le Bourdelles S, Ades L, Ala-kokko L, Booms P, Boxer M, Child A, Comeqlio P, De Paepe A, Hvland JC, Holman K, Kaitila I, Loeys B, Matyas G, Nuvtinck L, Peltonen L, Rantamanki T, Robinson P, Steinmann B, Junien C, Beroud C, Boileau C. Update of the UMD-FBN1mutation database and creation of an FBN1 polymorphism database. Hum Mutat, 2003, 22(3): 199–208.
[4] Robinson PN, Godfrey M. The molecular genetic of Mar-fan syndrome and related microfibrillopathies. J Med Genet, 2000, 37(1): 9–25.
[5] Robinson PN, Booms P, Katzke S, Ladewiq M, Neumann L, Palz M, Preqla R, Tieche E, Rosenberq T. Mutation of FBN1 and genotype correlations in Marfan syndrome and related fi-brillinopathies. Hum Mutat, 2002, 20(3): 153–161.
[6] Korkko J, Kaitila I, Lonnqvist L, Peltonen L, Ala-Kokko L. Sensitivity of conformation sensitive gelelectrophoresis in detecting mutations in Marfan syndrome and related con-ditions. J Med Genet, 2002, 39(1): 34–41.
[7] Nijbroek G, Sood S, McIntosh I, Francomano CA, Bull E, Pereira L, Ramirez F, Pyeritz RE, Dietz HC. Fifteen novel FBN1 mutation causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet, 1995, 57(1): 8–21.
[8] 伍严安, 陈喜军, 黄肖利, 陈同, 陈发文, 陈发林, 黄毅. Marfan综合征FBN1基因新的剪接位点的置换突变. 福建医科大学学报, 2007, 41(2): 156–158.
[9] Matyas G, De Paepe A, Halliday D, Boileau C, Pals G, Steinmann B. Evaluation and application of denaturing HPLC for mutations detection in Marfan syndrome: iden-tification of 20 novel mutation and two novel polymor-phisms in the FBN1 gene. Hum Mutat, 2002, 19(4): 443–456.
[10] Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kaiii T, Jondeau G, Ohta T, Kishino T, Furukawa Y,Nakamura Y, Niikawa N, Boileau C, Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet, 2004, 36(8): 855–860.
[11] Singh KK, Rommel K, Mishra A, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys–Dietz syndrome. Hum Mutat, 2006, 27(8): 770–777.
[12] Boileau C, Jondeau G, Mizuguchi T, Matsumoto N. Mo-lecular genetics of Marfan syndrome. Curr Opin Cardiol, 2005, 20(3): 194–200.
[13] Dietz HC, McIntosh I, Sakai LY, Corson GM, Chalberq SC, Pveritz RE, Francomano CA. Four novel FBN1 muta-tions: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics, 1993, 17(2): 468–475.
[14] Pereira L, Lee SY, Gayraud B, Andrikopoukos K, Shapiro SD, Bunton T, Bierv NJ, Dietz HC, Sakai LY, Ramirez F. Pathogenetic sequence for aneurysm revealed in mice un-derexpressing fibrillin-1. Proc Natl Acad Sci USA, 1999, 96(7): 3819–3823.
[15] Reinhardt DP, Ono RN, Notbohm H, Muller PK, Bachin-qer HP, Sakai LY. Mutation in calcimu-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome. J Biol Chem, 2000, 275(16): 12339–12345. |